Study for Rasagiline Effect on Sleep Trial(REST)in Parkinson's Disease
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The main objective of this study is to evaluate the effect of Azilect® on sleep disturbances
in Parkinson's Disease patients, after 2 months of treatment.
Details
Lead Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc. Teva Pharmaceutical Industries